Volume 18, Number 6—June 2012
CME ACTIVITY - Research
Pretransplant Fecal Carriage of Extended-Spectrum β-Lactamase–producing Enterobacteriaceae and Infection after Liver Transplant, France
|Age, y, mean ± SD||50 ± 11|
|Male sex||490 (69)|
|Viral hepatitis||261 (36.7)|
|Hepatocellular carcinoma||221 (31.1)|
|Acute liver failure||74 (10.4)|
|Biliary disease||61 (8.6)|
|HIV infection||21 (3)|
|MELD score, mean ± SD||18 ± 9|
*Values are no. (%) patients except as indicated. ESBLE, extended spectrum β-lactamase–producing Enterobacteriaceae; MELD, Model for End-stage Liver Disease.
Page created: May 17, 2012
Page updated: May 17, 2012
Page reviewed: May 17, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.